Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

Sex bias and maternal contribution to gene expression divergence in Drosophila blastoderm embryos

ABSTRACT: Early embryogenesis is a unique developmental stage where genetic control of development is handed off from mother to zygote. Yet the contribution of this transition to the evolution of gene expression is poorly understood. Here we study two aspects of gene expression specific to early embryogenesis in Drosophila: sex-biased gene expression prior to the onset of canonical X chromosomal dosage compensation, and the contribution of maternally supplied mRNAs. We sequenced mRNAs from individual unfertilized eggs, precisely staged and sexed blastoderm embryos and compared levels between D. melanogaster, D. yakuba, D. pseudoobscura and D. virilis. First, we find that mRNA content is highly conserved for a given stage and that studies relying on pooled embryos may systematically overstate the degree of gene expression divergence. Unlike studies done on larvae and adults, where most species show a larger proportion of genes with male-biased expression, we find that transcripts in Drosophila embryos are largely female-biased in all species, likely due to incomplete dosage compensation prior to the activation of the canonical dosage compensation mechanism. The divergence of sex-biased gene expression across species is observed to be often due to a decrease of expression, the most drastic example of which is the overall reduction of male expression from the neo-X chromosome in D. pseudoobscura, leading to a pervasive female-bias on this chromosome. We see no evidence for a faster evolution of expression on the X chromosome in embryos (no “faster X” effect), unlike in adults and contrary to a previous study on pooled non-sexed embryos. Finally, we find that most genes are conserved in regard to their maternal or zygotic origin of transcription, and present evidence that differences in maternal contribution to the blastoderm transcript pool may be due to species-specific divergence of transcript degradation rates We sequenced mRNA from D. melanogaser, D. yakuba, D. pseudoobscura and D. virilis single unfertilized eggs (1 to 2 per species) and from both single female and male embryos (3 per sex per species).

ORGANISM(S): Drosophila virilis

SUBMITTER: Mathilde Paris

PROVIDER: E-GEOD-68062 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Similar Datasets

Project description:Cyanobacteria are complex prokaryotes, incorporating a Gram-negative cell wall and internal thylakoid membranes (TM). However, localisation of proteins within cyanobacterial cells is poorly understood. Using subcellular fractionation and quantitative proteomics we report the first subcellular map of the proteome of an entire cyanobacterial (or any other prokaryotic) cell, identifying ~67% of Synechocystis sp. PCC 6803 proteins, ~1000 more than previous studies. 1,712 proteins were assigned to six specific subcellular regions. Proteins involved in energy generation localised to TMs. The majority of transporters, with the exception of the TM localised copper importer CtaA, resided in the plasma membrane (PM). Most metabolic enzymes are soluble although numerous pathways terminated in the TM (notably those involved in peptidoglycan monomer, NADP+, heme, lipid and carotenoid biosynthesis), or the PM (specifically those catalysing lipopolysaccharide, molybdopterin, flavin adenine dinucleotide and menaquinone biosynthesis). Furthermore, we identified the proteins involved in the TM and PM electron transport chains. The majority of ribosomal proteins and enzymes synthesising the storage compound polyhydroxybuyrate formed distinct clusters within the data suggesting that they have similar subcellular distributions to one another as one would expect for proteins operating within multi-component protein structures. Moreover, heterogeneity within membrane and cytoplasmic regions is observed, indicating further cellular complexity. Cyanobacterial TM protein localisation is conserved in Arabidopsis thaliana chloroplasts, suggesting similar proteome organisation in higher photosynthetic organisms. The organisation of a cyanobacterial cell revealed here will significantly aid our understanding of these environmentally and biotechnological important organisms. The successful application of this technique in Synechocystis suggests it could be applied to mapping the proteomes of other cyanobacteria and complex single-celled organisms.

Project description:Background: The mammary gland is a dynamic organ that undergoes important physiological changes during reproductive cycles. Until now, data regarding the characterisation of miRNA in the mammary gland have been scarce and mainly focused on their abnormal expression in breast cancer. Our goal was to characterise the microRNA (miRNA) involved in mechanisms regulating the mammary function, with particular focus on the lactation stage Methodology/principal findings: Using high-throughput sequencing technology, an exhaustive repertoire of miRNA (miRNome) expressed in mouse and bovine mammary glands during established lactation was identified, characterised and compared. Furthermore, in order to obtain more information on miRNA loading in the RNA-induced silencing complex (RISC), the miRNome was compared with that obtained from RNA associated with the AGO2 protein (AGO2-miRNome) in mouse lactating mammary gland. This study enabled the identification of 164 and 167 miRNA in mouse and bovine, respectively. Among the 30 miRNA most highly expressed in each species, 24 were common to both species and six of them tended to be more highly expressed in lactating than in non-lactating mammary gland. The potential functional roles of these 24 miRNA were deduced using DIANA-miRPath software, based on miRNA/mRNA interactions. Moreover, seven putative novel miRNA were identified. Using DAVID analysis, it was concluded that the predicted targets of two of these putative novel miRNA are involved in mammary gland morphogenesis. Conclusion/significance: Our study provides an overview of the characteristics of lactating mouse and bovine mammary gland miRNA expression profiles. Moreover, species-conserved miRNA involved in this fundamental biological function were identified. These miRNomes will new be used as references for further studies during which the impact of animal breeding on the miRNA expression will be analysed. microRNA profiles of mammary glands from 2 FVB/N mice at lactation day-12 and mammary biopsies from 4 Holstein dairy cows at mid-lactation, generated by deep sequencing, using Illumina HiSeq 2000.

Project description:Exon tiling array encompassing 837,251 probes across the mouse genome. 12 tissue pools. Composition of the 12 mRNA pools analyzed (mRNA per array hybridization): 1- Heart (2 microgram), Skeletal muscle (2 microgram) 2- Liver (2 microgram) 3- Whole brain (1.5 microgram), Cerebellum (0.48 microgram), Olfactory bulb (0.15 microgram) 4- Colon (0.96 microgram), Intestine (1.04 microgram) 5- Testis (3 microgram), Epididymis (0.4 microgram) 6- Femur (0.9 microgram), Knee (0.4 microgram), Calvaria (0.06 microgram), Teeth+mandible (1.3 microgram), Teeth (0.4 microgram) 7- 15 day Embryo (1.3 microgram), 12.5 day Embryo (12.5 microgram), 9.5 day Embryo (0.3 microgram), 14.5 day Embryo head (0.25 microgram), ES cells (0.24 microgram) 8- Digit (1.3 microgram), Tongue (0.6 microgram), Trachea (0.15 microgram) 9- Pancreas (1 microgram), Mammary gland (0.9 microgram), Adrenal gland (0.25 microgram), Prostate gland (0.25 microgram) 10- Salivary gland (1.26 microgram), Lymph node (0.74 microgram) 11- 12.5 day Placenta (1.15 microgram), 9.5 day Placenta (0.5 microgram), 15 day Placenta (0.35 microgram) 12- Lung (1 microgram), Kidney (1 microgram), Adipose (1 microgram), Bladder (0.05 microgram) Labeling and hybridization: mRNA pools were reverse-transcribed with random nonamer primers (1 microgram/reaction) and T18VN (0.25 microgram/reaction) to synthesize cDNA. The reaction contained a 1:1 mixture of 5-(3-aminoallyl) thymidine 5'-triphosphate (Sigma, St. Louis, MO) and thymidine triphosphate (TTP) in place of TTP. cDNA products were bound to QIAquick PCR Purification columns (Qiagen, Germany) following the manufacturer's instructions, washed three times with 80% ethanol, and eluted with water. Purified cDNA was reacted with N-hydroxy succinimide esters of Cy3 or Cy5 (Amersham Pharmacia Biotech, Piscataway, NJ) following the manufacturer's instructions. Hydroxylamine-quenched Cy-labeled cDNAs were separated from free dye molecules using QIAquick columns. Mixed labeled cDNAs were added to hybridization buffer containing 1 M NaCl, 0.5% sodium sarcosine, 50 mM methyl ethane sulfonate (MES), pH 6.5, 33% formamide and 40 Âµg herring sperm DNA (Invitrogen, Carlsbad, California). Hybridizations were carried out in a final volume of 0.5 ml injecting into an Agilent hybridization chamber at 42Â°C on a rotating platform in a hybridization oven (Robbins Scientific Corporation, Sunnyvale, California) for 16-24 h. Slides were then washed (rocking ~30 seconds in 6x SSPE, 0.005% sarcosine, then rocking ~30 seconds in 0.06x SSPE) and scanned with a 4000A microarray scanner (Axon Instruments, Union City, California). Each array was hybridized with two samples simultaneously, each from a different pool. Image processing and data normalization: TIFF images were quantitated with GenePix (Axon Instruments). Individual channels were spatially detrended (i.e overall correlations were removed between spot intensity and position on the slide) by subtracting from each spot's log intensity a weighted average of the log intensities of nearby spots. Most weights were a product of two Gaussian functions, one of the difference in rows between the spots and one of the difference in columns, however 10% of the spots ("high expressors") were always assigned a weight of zero. The widths of the row and column Gaussians were chosen to minimize the sum, across all spots, of the squared difference between the weighted average and the actual log intensity of the spots. The "high expressors" spots were those with the largest difference between their log intensity and the median log intensity over a 7x7 window of neighboring spots. After spatial detrending, we transformed the log intensities back into linear intensities and all single-channels were normalized to each other (in the linear domain), using channel-specific affine transforms. That is, for each single channel, we normalized all the detrending intensities by adding an offset parameter (which was possibly negative) and then multiplying by a positive scale parameter. The scale and offset parameters of each channel's transform were set so that the median intensities and the difference between the 75th and 25th percentile intensities were identical across channels.

Project description:Rationale There is a need for new and better biomarkers for hypertrophic cardiomyopathy (HCM) which correlate more closely with disease progression as determined by clinical imaging and biohumoral information. We have used a combination of heart tissue and plasma proteomics to identify potential biomarkers for HCM and developed them into an exploratory targeted proteomic assay. Objective To identify informative staging biomarkers for HCM and develop them into a blood test. The test using 10 µl of plasma, was developed into a 10 min liquid chromatography-tandem/mass spectrometry (LC-MS/MS) assay to analyze multiple candidate biomarkers and evaluate their association with clinical phenotypes in patients with HCM. Methods and Results Myocardial tissue and plasma samples from patients with HCM and healthy volunteers (controls) were screened using a combined gel- and nano-LC quadrupole time of flight MS approach. Twenty-six potential biomarkers were identified from the proteomics screens and developed into a multiplexed targeted proteomic assay. Their association with clinical phenotypes was tested in plasma samples collected from 207 prospectively recruited participants: 110 patients with HCM (50.1 ± 15.0 years, 70% male; 48 [44%] with identified genetic mutations) and 97 controls (49.6 ± 13.4 years, 58% male), randomly split into training (80 HCM, 67 controls) and validation datasets (30 HCM, 30 controls). Six markers (Aldolase Fructose-Bisphosphate A, Complement C3, Glutathione S-Transferase Omega 1, Ras Suppressor Protein 1, Talin 1, and Thrombospondin 1) were significantly increased (P<0.006) in the plasma of HCM patients compared to controls in the training dataset. These markers correlated with left ventricular (LV) wall thickness, LV mass and % myocardial scar on cardiovascular magnetic resonance imaging. Using supervized machine learning (ML) this panel differentiated HCM from controls (area under the curve: 0.89 in the training dataset, sensitivity 96%, 95% confidence interval [CI] 77–93; specificity 87%, 95%CI 77–94; and 0.87 in the validation dataset, sensitivity 97%, 95%CI 83–100; specificity 77%, 95%CI 58–90). Four of the biomarkers as well as the composite ML score of the plasma proteome correlated with the presence of nonsustained ventricular tachycardia and the estimated 5-year risk of sudden cardiac death. Conclusion By developing a high-throughput, multiplex, and targeted proteomic plasma assay we identified 6 biomarkers that correlate with the presence of disease and with clinical risk score for sudden cardiac death.

Dataset Information

Sex bias and maternal contribution to gene expression divergence in Drosophila blastoderm embryos

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure